Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2018-08-07 Major Shareholding Noti…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number' and contains the standard structure for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing type concerning share ownership thresholds, making MRQ the most precise classification over the general RNS fallback.
2018-08-07 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is explicitly labeled with an 'RNS Number' and contains a 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This structure details a transaction (grant of options) involving a Director/PDMR (Chief Financial Officer). This falls directly under the definition of Director's Dealing (insider trades). Although it is distributed via RNS, the specific content mandates the 'DIRS' code over the general 'RNS' fallback. The document length is short (4220 chars), but it is the primary disclosure, not an announcement of a separate report.
2018-08-06 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the RNS Number (7942W) and explicitly mentions 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. It details a purchase of shares by a Non-Executive Director (Mr Sten Scheibye). This directly corresponds to the definition of Director's Dealing (insider trades). The presence of the RNS header and the nature of the disclosure strongly point to DIRS. Although it is distributed via RNS, the specific content is about insider transactions, making DIRS the most precise classification.
2018-08-03 English
ConvaTec Group Plc First Half Results 2018
Interim / Quarterly Report Classification · 95% confidence The document is a formal announcement of 'First Half Results 2018' for ConvaTec Group PLC. It contains detailed financial highlights, franchise performance summaries, and tables comparing 2018 and 2017 financial data (revenue, EBIT, margins). While it is an announcement, it provides substantive financial data and analysis for the interim period (six months ended 30 June 2018), which qualifies it as an Interim/Quarterly Report under the provided definitions. H1 2018
2018-08-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified as an 'RNS Number' notification for 'ConvaTec Group PLC' dated '27 July 2018'. The form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2018-07-27 English
US FDA 510(k) Clearance for AQUACELT Ag Advantage
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated July 24, 2018. It announces that ConvaTec Group PLC received U.S. FDA 510(k) clearance for a new medical dressing product (AQUACEL™ Ag Advantage dressing). This is a specific, material announcement released via the London Stock Exchange's news service (RNS). Since it is a specific regulatory/news announcement that doesn't fit the definitions for ER (Earnings Release), CAP (Financing), or DIRS (Insider Trading), the most appropriate classification is RNS, which serves as the general regulatory announcement category for LSE filings that are not otherwise specified (like 10-K, DEF 14A, etc.). The document is not a report itself, but an announcement of a regulatory clearance.
2018-07-24 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.